The American Cancer Society Cancer Action Network (ACS CAN) and the HL7 FHIR Accelerator™ Common Oncology Data Elements eXtensions (CodeX) are working together with partners on a project to increase and expand patient enrollment in cancer clinical trials at smaller and non-research oriented medical centers.
A new report from the American Cancer Society Cancer Action Network (ACS CAN) takes an in-depth look at disparities across all areas of cancer research and suggests immediate policy solutions that could help address such gaps in the years to come.
A group of more than fifty cancer research-focused organizations are urging Congress to include $10 billion in emergency funding to restart cancer research and clinical trials at the National Institutes of Health (NIH) stalled by the coronavirus pandemic.
ACS CAN President Lisa Lacasse reacts to President Biden's declaration we will, "End cancer as we know it." The statement was part of the president's address to a joint session of Congress.
BATON ROUGE, LA – As lawmakers dive into the new legislative session, the American Cancer Society Cancer Action Network (ACS CAN) looks ahead to what public health initiatives our lawmakers can accomplish during the 2021 legislative session.
Karen E. Knudsen, MBA, Ph.D., will be the next chief executive officer of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), starting June 1, 2021. She will take the reins from the retiring Gary Reedy, who has served as both organizations’ CEO since 2015.
Today the Biden administration released preliminary details on its FY 2022 discretionary budget, including $6.5 billion to create a new department within the National Institutes of Health (NIH) dedicated to accelerating the pace of biomedical research for rare and difficult to treat diseases.
HONOLULU—Today, state lawmakers heard from cancer patients, survivors and volunteer advocates from across the state during a virtual Cancer Action Day, hosted by the American Cancer Society Cancer Action Network (ACS CAN).
The U.S. House of Representatives is likely to pass legislation today that would increase access to health coverage for millions of Americans, including cancer patients and survivors, as part of its pandemic relief package.
Congress approved an FY 2021 funding deal that includes an increase for biomedical research funding at the National Institutes of Health (NIH) and cancer research at the National Cancer Institute (NCI).